Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management

Chiara Casadei, Giuseppe Schepisi, Cecilia Menna, Michal Chovanec, Giorgia Gurioli, Valentina Gallà, Amelia Altavilla, Massimo Marcellini, Salvatore Roberto Bellia, Cristian Lolli, Michal Mego, Giovanni Rosti, Ugo De Giorgi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Germ cell tumors represent 11% of the cancers diagnosed in adolescent males and are the most common solid tumors in adult men between the ages of 20 and 35. Pure seminoma accounts for around 50% of all testicular germ cell tumors. The prognostic classification of the International Germ Cell Cancer Collaborative Group for good-prognosis seminoma includes both nodal disease and pulmonary visceral metastases. In this article, we analyzed recent data on prognosis and outcome of good-prognosis seminoma to revise the traditional classification of the disease and improve tailored treatment.

Original languageEnglish
Pages (from-to)1347-1352
Number of pages6
JournalFuture Oncology
Volume15
Issue number12
DOIs
Publication statusPublished - Apr 1 2019

Fingerprint

Seminoma
Biomarkers
Germ Cell and Embryonal Neoplasms
Lung Diseases
Neoplasms
Neoplasm Metastasis
Therapeutics

Keywords

  • biomarkers
  • bleomycin
  • chemotherapy
  • germ cell tumors
  • high-dose
  • human chorionic gonadotropin
  • metastases
  • platinum
  • prognosis
  • seminoma
  • α-fetoprotein

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Reclassification of good-risk seminoma : Prognostic factors, novel biomarkers and implications for clinical management. / Casadei, Chiara; Schepisi, Giuseppe; Menna, Cecilia; Chovanec, Michal; Gurioli, Giorgia; Gallà, Valentina; Altavilla, Amelia; Marcellini, Massimo; Bellia, Salvatore Roberto; Lolli, Cristian; Mego, Michal; Rosti, Giovanni; De Giorgi, Ugo.

In: Future Oncology, Vol. 15, No. 12, 01.04.2019, p. 1347-1352.

Research output: Contribution to journalArticle

Casadei, C, Schepisi, G, Menna, C, Chovanec, M, Gurioli, G, Gallà, V, Altavilla, A, Marcellini, M, Bellia, SR, Lolli, C, Mego, M, Rosti, G & De Giorgi, U 2019, 'Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management', Future Oncology, vol. 15, no. 12, pp. 1347-1352. https://doi.org/10.2217/fon-2018-0850
Casadei, Chiara ; Schepisi, Giuseppe ; Menna, Cecilia ; Chovanec, Michal ; Gurioli, Giorgia ; Gallà, Valentina ; Altavilla, Amelia ; Marcellini, Massimo ; Bellia, Salvatore Roberto ; Lolli, Cristian ; Mego, Michal ; Rosti, Giovanni ; De Giorgi, Ugo. / Reclassification of good-risk seminoma : Prognostic factors, novel biomarkers and implications for clinical management. In: Future Oncology. 2019 ; Vol. 15, No. 12. pp. 1347-1352.
@article{d8738318f80044e1992e2894dd891125,
title = "Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management",
abstract = "Germ cell tumors represent 11{\%} of the cancers diagnosed in adolescent males and are the most common solid tumors in adult men between the ages of 20 and 35. Pure seminoma accounts for around 50{\%} of all testicular germ cell tumors. The prognostic classification of the International Germ Cell Cancer Collaborative Group for good-prognosis seminoma includes both nodal disease and pulmonary visceral metastases. In this article, we analyzed recent data on prognosis and outcome of good-prognosis seminoma to revise the traditional classification of the disease and improve tailored treatment.",
keywords = "biomarkers, bleomycin, chemotherapy, germ cell tumors, high-dose, human chorionic gonadotropin, metastases, platinum, prognosis, seminoma, α-fetoprotein",
author = "Chiara Casadei and Giuseppe Schepisi and Cecilia Menna and Michal Chovanec and Giorgia Gurioli and Valentina Gall{\`a} and Amelia Altavilla and Massimo Marcellini and Bellia, {Salvatore Roberto} and Cristian Lolli and Michal Mego and Giovanni Rosti and {De Giorgi}, Ugo",
year = "2019",
month = "4",
day = "1",
doi = "10.2217/fon-2018-0850",
language = "English",
volume = "15",
pages = "1347--1352",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "12",

}

TY - JOUR

T1 - Reclassification of good-risk seminoma

T2 - Prognostic factors, novel biomarkers and implications for clinical management

AU - Casadei, Chiara

AU - Schepisi, Giuseppe

AU - Menna, Cecilia

AU - Chovanec, Michal

AU - Gurioli, Giorgia

AU - Gallà, Valentina

AU - Altavilla, Amelia

AU - Marcellini, Massimo

AU - Bellia, Salvatore Roberto

AU - Lolli, Cristian

AU - Mego, Michal

AU - Rosti, Giovanni

AU - De Giorgi, Ugo

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Germ cell tumors represent 11% of the cancers diagnosed in adolescent males and are the most common solid tumors in adult men between the ages of 20 and 35. Pure seminoma accounts for around 50% of all testicular germ cell tumors. The prognostic classification of the International Germ Cell Cancer Collaborative Group for good-prognosis seminoma includes both nodal disease and pulmonary visceral metastases. In this article, we analyzed recent data on prognosis and outcome of good-prognosis seminoma to revise the traditional classification of the disease and improve tailored treatment.

AB - Germ cell tumors represent 11% of the cancers diagnosed in adolescent males and are the most common solid tumors in adult men between the ages of 20 and 35. Pure seminoma accounts for around 50% of all testicular germ cell tumors. The prognostic classification of the International Germ Cell Cancer Collaborative Group for good-prognosis seminoma includes both nodal disease and pulmonary visceral metastases. In this article, we analyzed recent data on prognosis and outcome of good-prognosis seminoma to revise the traditional classification of the disease and improve tailored treatment.

KW - biomarkers

KW - bleomycin

KW - chemotherapy

KW - germ cell tumors

KW - high-dose

KW - human chorionic gonadotropin

KW - metastases

KW - platinum

KW - prognosis

KW - seminoma

KW - α-fetoprotein

UR - http://www.scopus.com/inward/record.url?scp=85065079480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065079480&partnerID=8YFLogxK

U2 - 10.2217/fon-2018-0850

DO - 10.2217/fon-2018-0850

M3 - Article

C2 - 30880465

AN - SCOPUS:85065079480

VL - 15

SP - 1347

EP - 1352

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 12

ER -